Tc-99m Radiolabeled Peptide p5 + 14 is an Effective Probe for SPECT Imaging of Systemic Amyloidosis

[1]  Shelley N. Acuff,et al.  A Routine PET/CT Protocol with Streamlined Calculations for Assessing Cardiac Amyloidosis Using 18F-Florbetapir , 2015, Front. Cardiovasc. Med..

[2]  E. Uberbacher,et al.  Preclinical Validation of the Heparin-Reactive Peptide p5+14 as a Molecular Imaging Agent for Visceral Amyloidosis , 2015, Molecules.

[3]  Xiang-yi Ma,et al.  Evaluation of (99m)Tc-HYNIC-TMTP1 as a tumor-homing imaging agent targeting metastasis with SPECT. , 2015, Nuclear medicine and biology.

[4]  Anil Kumar,et al.  A review on Alzheimer’s disease pathophysiology and its management: an update , 2015, Pharmacological reports : PR.

[5]  R. Falk,et al.  Imaging cardiac amyloidosis: a pilot study using 18F-florbetapir positron emission tomography , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[6]  B. Hazenberg,et al.  Bone scintigraphy with 99mtechnetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis , 2014, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[7]  G. Merlini,et al.  Systemic light chain amyloidosis: an update for treating physicians. , 2013, Blood.

[8]  S. Kennel,et al.  A Binding-Site Barrier Affects Imaging Efficiency of High Affinity Amyloid-Reactive Peptide Radiotracers In Vivo , 2013, PloS one.

[9]  P. Hawkins,et al.  Systemic Amyloidosis in England: an epidemiological study , 2013, British journal of haematology.

[10]  D. Selkoe,et al.  Biochemistry of amyloid β-protein and amyloid deposits in Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.

[11]  G. Merlini,et al.  AA amyloidosis: basic knowledge, unmet needs and future treatments. , 2012, Swiss medical weekly.

[12]  S. Kennel,et al.  In vivo molecular imaging of peripheral amyloidosis using heparin-binding peptides , 2011, Proceedings of the National Academy of Sciences.

[13]  Keiichi Magota,et al.  Performance characterization of the Inveon preclinical small-animal PET/SPECT/CT system for multimodality imaging , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[14]  S. Kennel,et al.  Radioimmunodetection of amyloid deposits in patients with AL amyloidosis. , 2010, Blood.

[15]  S. Kennel,et al.  Quantitative tomography of early-onset spontaneous AA amyloidosis in interleukin 6 transgenic mice. , 2008, Comparative medicine.

[16]  A. Bruskin,et al.  In vivo evaluation of cysteine-based chelators for attachment of 99mTc to tumor-targeting Affibody molecules. , 2007, Bioconjugate chemistry.

[17]  B. Hazenberg,et al.  Diagnostic performance of 123I-labeled serum amyloid P component scintigraphy in patients with amyloidosis. , 2006, The American journal of medicine.

[18]  F. Salvi,et al.  Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy. , 2005, Journal of the American College of Cardiology.

[19]  B. Hesse,et al.  99mTc-aprotinin scintigraphy in amyloidosis. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  M. Schell,et al.  Thermodynamic instability of human lambda 6 light chains: correlation with fibrillogenicity. , 1999, Biochemistry.

[21]  M. Schell,et al.  Transgenic mouse model of AA amyloidosis. , 1999, The American journal of pathology.

[22]  G. Merlini,et al.  Cardiac and pleuropulmonary AL amyloid imaging with technetium-99m labelled aprotinin , 1995, European Journal of Nuclear Medicine.

[23]  K Ogawa,et al.  Simulation study of triple-energy-window scatter correction in combined Tl-201, Tc-99m SPECT , 1994, Annals of nuclear medicine.

[24]  P. Hawkins.  Diagnosis and monitoring of amyloidosis. , 1994, Bailliere's clinical rheumatology.

[25]  L. Feldkamp,et al.  Practical cone-beam algorithm , 1984 .

[26]  M. Ramirez-Alvarado,et al.  Systemic amyloidoses. , 2013, Annual review of biochemistry.

[27]  C. Donadio,et al.  99mTc-aprotinin: A new tracer for kidney morphology and function , 2004, European Journal of Nuclear Medicine.

[28]  A. Salvadeo,et al.  Assessment of split renal function with99mTc-aprotinin , 2004, European Journal of Nuclear Medicine.